News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Madison Vaccines Announces The Appointment Of Michael Richman To Its Board Of Directors


5/14/2014 7:24:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Madison Vaccines Incorporated (MVI), a clinical stage biopharmaceutical company focused on advancing innovative therapies for prostate cancer, today announced the appointment of Michael Richman to its Board of Directors. Mr. Richman has almost 30 years’ experience working in pharmaceutical research and business development.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES